June 2013 - QualityStocks

FridayJun 28, 2013 3:43 pm

South American Gold Corp. (SAGD) Offers Operational Update and Corporate Project Overview for 2013 Activities

South American Gold has assembled a nice portfolio of gold and silver exploration interests, both at home here in the U.S. with their New Light Mine gold-silver project up in northern Washington State, the Baltimore Silver project in Montana, the newer Kelly Project group of mining claims in western Montana, and the GB-2 mining claims in Arizona, as well as abroad in Colombia via the Narino Department in the south and the Santacruz Gold project. Today the company was pleased to offer markets a sweeping update on their 2013 activities and developments. The company is hard at work vetting existing…

FridayJun 28, 2013 1:02 pm

The Guitammer Company (GTMM) – Technological Evolution in Motion

The Guitammer Company was founded by musician, composer, and producer Ken McCaw, who was looking for a way to commercialize a patented guitar accessory called the Hammer Jammer. The next product to emerge from Guitammer was the solution to a problem McCaw and his drummer were experiencing in wanting to be able to feel the low end without turning the stage monitors up so loud that it disturbed the rest of the band. This was the moment the idea for ButtKicker® brand low frequency audio transducers were born, offering monitoring, timing, and synchronization by allowing the musicians to feel the…

FridayJun 28, 2013 12:31 pm

VistaGen Therapeutics, Inc. (VSTA) Issues Update on $36M Strategic Financing Agreement with Autlion

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Stem Cell Research (ISSCR), the largest forum for stem cell and regenerative medicine professionals from around the world, held last week in Boston, Massachusetts. Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that…

FridayJun 28, 2013 12:16 pm

Biostem U.S. Corporation (HAIR) Spammed Aggressively

We have observed an unsolicited emails spamming Biostem. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net. QualityStocks also helps protect investors by rating thousands…

FridayJun 28, 2013 11:55 am

VentriPoint Diagnostics Ltd. (VPTDF) Offers Superior Solution to Right Heart Analysis

VentriPoint Diagnostics is a Seattle-based provider of a superior heart analysis system. The VentriPoint technology uses conventional 2-dimensional ultrasound data, plus a patented system for analyzing the data called Knowledge-Based Reconstruction (KBR). The result is a 3-dimensional model of the heart, providing critical information regarding things like heart volumes and cardiac output. The VentriPoint system, called Angelo, is of special value for doing what is called right-heart analysis, where the physician needs a clear view of the portion of the heart that pumps blood to the lungs for oxygenation. It is normally difficult to image the right heart using ultrasound,…

FridayJun 28, 2013 11:43 am

TeleCommunication Systems Inc. (TSYS) Video Chart for Friday, June 28, 2013

TSYS has made a strong move over the past week to rise about 20 percent to face a resistance point at $2.40. Should the pps break the resistance, which will keep it over the 50-day and 200-day moving averages, there is not much resistance until old highs at $2.70. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayJun 28, 2013 10:04 am

QualityStocks Productions Releases Rafarma Pharmaceuticals, Inc. (RAFA) Video Exposing Company’s Strategic Position

The Russian pharmaceutical sector is roaring forward, estimated to reach a value of $10.7 billion by 2014 and $60 billion by 2020, fueled by the Russian Government’s initiatives to bolster the country’s domestic pharmaceutical market. Rafarma Pharmaceuticals aims to take its fair share of the market and emerge as one of the Top 3 Russian pharmaceutical companies within the next decade. To reach this goal, Rafarma has built a new world-class 270,000 square-foot manufacturing plant in a strategic location and operated by a highly classified management team. A recent video published by QualityStocks Productions highlights Rafarma’s position in the burgeoning…

FridayJun 28, 2013 9:41 am

Minerco Resources, Inc. (MINE) Subsidiary Receives License for Universal Product Code Company Prefix

Minerco Resources, a progressive developer, producer, and provider of worldwide commodities solutions, today announced that Level 5 Beverage Company, Inc., the company's subsidiary, has received its Universal Product Code (U.P.C.) Company Prefix from GS1 US. The License was issued to Level 5 for its GS1 Company Prefix (0851012005), its U.P.C. Company Prefix (851012005), and its Global Location Number (GLN 0851012005008). This license, including GS1 membership, entitles Level 5 to create up to 100 distinct Global Trade Item Numbers (GTINs) including U.P.C.s and SKU numbers. Used exclusively within GS1 identification standards, the GS1 Company Prefix may be expressed in GS1 approved…

FridayJun 28, 2013 9:38 am

Access Pharmaceuticals, Inc. (ACCP) Reports Favorable MuGard™ Trial Results, Presented at MASCC/ISOO International Symposium on Supportive Care in Cancer

Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, has presented top-line results from a phase IV clinical trial evaluating Access Pharmaceuticals’ MuGard™ Mucoadhesive Oral Wound Rinse at the MASCC/ISOO International Symposium on Supportive Care in Cancer in Berlin, Germany. The study evaluated the efficacy of MuGard in controlling symptoms caused by oral mucositis, a side effect of some radiation and chemotherapy cancer treatments. The presentation, entitled "The Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of MuGard in Mitigating Oral Mucositis (OM) in Chemoradiation-Treated Head and Neck Cancer Patients" summarized top-line data on 78 of the total…

FridayJun 28, 2013 9:36 am

Chembio Diagnostics, Inc. (CEMI) Announces Membership in Russell Global Index

Point-of-care diagnostics test leader Chembio Diagnostics announced it will soon join the Russell Global Index. According to a preliminary list of additions posted on June 21 at www.russell.com/indexes, the listing will happen on June 28, when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes. Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell’s equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio’s stock will be included…

Site Search

Company Search

Month: June 2013